Novavax Inc (NASDAQ:NVAX) opened its previous trading session at $1.08 later Inclining 1.85% to close its trade at a share price of $1.1.
During the trading day, the stock price fluctuated between $1.08 and $1.14.
The Stock traded with an actual day volume of 3.09 Million and average volume of 6.5 Million respectively.
The current market capitalization of Novavax Inc (NASDAQ:NVAX) stands at 318.91 Million.
The stock Hit its 1-year high of $8.49 on 09/15/16 and its 1-year low price of $0.73 on 05/08/17.
Novavax Inc (NASDAQ:NVAX) currently has a trailing P/E of -1.43 while its forward P/E according to Thomson Reuters is -1.96.
NVAX’s fiscal year ends Dec 31, 2016 and the most recent quarter started on Jun 30, 2017.
Talking about profitability of the company, the profit margin percentage is 0% while its operating margin for the trailing twelve month is at -931.71%.
Management effectiveness shows return on equity and return on assets for the trailing twelve months at -829.23% and -27.83% respectively.
What does the Income statement say?
By having an overview of the Income statement for Novavax Inc (NASDAQ:NVAX) the Revenue for the trailing twelve months is 21.04 Million.
- Revenue per share is 0.08.
- Quarterly Revenue growth year over year is 168.7 Percent. Gross Profit (ttm) is 15350.
- EBITDA stands at -186640000.
According to Balance Sheet of NVAX, Total cash on most recent quarter is 187.31 Million.
Total cash per share on the most recent quarter is 0.65. Total Debt is 317.05 Million.
The Average Volume for 10 days is 4.35 Million for Novavax Inc (NASDAQ:NVAX). The total number of Outstanding Shares is 289.92 Million. Float is at 285.61 Million.
The stock shows a Short Ratio of 5.54 with the total number of Shares Short (Previous Month) of 55.51 Million.
The stock is currently moving with a Negative distance from 200-Day Simple Moving Average of about -7% and has no so good Year to Date (YTD) Performance of -12.7% which means the stock is constantly adding to its value from previous fiscal year end price.
Dividends & Splits:
In the last reported quarter, Novavax Inc reported its Actual EPS (earnings per share) of $-0.16/share where most of the analysts working on this stock were estimating the EPS to be $-0.16/share.
So the company beats the analysts estimate by $0/share showing a surprise of 0%.
What is the Fate of the Stock in the Future?
The Target Price for Novavax Inc (NASDAQ:NVAX) is $1.78/share according to the consensus analysis of analysts working on the stock.
According to the analysts, Novavax Inc (NASDAQ:NVAX) is expected to announce $-0.16/share EPS for the current quarter.